Great Lakes Drug Development
and Quantitative Solutions

Great Lakes Drug Development (GLDD) provides strategic, operational and interim management support for early drug development projects. The GLDD team devises & implements efficient, integrated, model-based development strategies focused on key decision points and value creation. GLDD utilizes the latest pharmacometric techniques, which integrate relevant data to guide early, informed decision making. GLDD also offers program management, clinical operations, regulatory, pharmacokinetic and biostatistics consulting. GLDD’s clients include intellectual property owners, venture capital firms, small and large pharma companies.

Quantitative Solutions and Great Lakes Drug Development have an ongoing collaboration on an early development project in the Cardiovascular therapeutic area. The collaboration significantly expands GLDD’s modeling and simulation capacity, and provides Quantitative Solutions with opportunities to develop and use its therapeutic databases to impact drug development strategy.